Client Result
Carlyle and SK Capital Complete Acquisition of bluebird bio
2 minute read | June.12.2025

2 minute read | June.12.2025
1 minute read | April.25.2025
1 minute read | April.15.2025
1 minute read | May.06.2024
Meta prevails in important test of corporate law protections, earning Orrick recognition in Litigators of the Week.
June.27.2022
The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.
September.29.2021
August.23.2016